An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon.
作者信息
Mauro Endri, Pedata Mariangela, Ermacora Anna, Mazzaro Cesare
机构信息
Section of Haematology and BMT Unit, Cremona Hospital, Cremona, Italy.
出版信息
Blood Transfus. 2012 Jan;10(1):101-3. doi: 10.2450/2011.0006-11. Epub 2011 Jul 18.
Abstract
摘要
相似文献
1
An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon.一名丙型肝炎病毒相关混合性冷球蛋白血症和惰性非霍奇金淋巴瘤患者，此前接受过干扰素治疗，在使用利妥昔单抗后，加用聚乙二醇干扰素和利巴韦林进行另一线治疗。
Blood Transfus. 2012 Jan;10(1):101-3. doi: 10.2450/2011.0006-11. Epub 2011 Jul 18.
2
3
Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.利妥昔单抗可诱导难治性丙型肝炎病毒相关冷球蛋白血症性血管炎缓解。
Ann Rheum Dis. 2003 Dec;62(12):1230-3. doi: 10.1136/ard.2002.004929.
4
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.一项 II 期、单臂、多中心研究，评估低剂量利妥昔单抗治疗丙型肝炎病毒感染相关性难治性混合性冷球蛋白血症。
Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5.
5
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.利妥昔单抗联合聚乙二醇干扰素-α/利巴韦林与聚乙二醇干扰素-α/利巴韦林在丙型肝炎相关混合性冷球蛋白血症中的比较。
Blood. 2010 Jul 22;116(3):326-34; quiz 504-5. doi: 10.1182/blood-2009-10-248518. Epub 2010 May 3.
6
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.聚乙二醇干扰素-α、利巴韦林和利妥昔单抗联合治疗丙型肝炎病毒相关混合性冷球蛋白血症：一项长期研究。
Blood. 2010 Jul 22;116(3):343-53. doi: 10.1182/blood-2009-10-245878. Epub 2010 Mar 22.
7
8
Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation.肝移植后采用干扰素α-2b和利巴韦林联合治疗使丙型肝炎病毒相关性冷球蛋白血症性肾小球肾炎缓解
Transplantation. 2002 Dec 27;74(12):1767-8. doi: 10.1097/00007890-200212270-00021.
9
Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.丙型肝炎病毒相关性非霍奇金淋巴瘤：无尽的历史。
Minerva Med. 2021 Apr;112(2):215-227. doi: 10.23736/S0026-4806.20.07184-0. Epub 2020 Dec 2.
10
The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia.单克隆抗体（利妥昔单抗）在II型混合性冷球蛋白血症治疗中的应用。
Braz J Infect Dis. 2007 Feb;11(1):174-5. doi: 10.1590/s1413-86702007000100038.
引用本文的文献
1
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.在抗CD20单克隆抗体和直接抗病毒药物时代治疗丙型肝炎病毒相关冷球蛋白血症性血管炎面临的挑战。
Oncotarget. 2017 Jun 20;8(25):41764-41777. doi: 10.18632/oncotarget.16986.
2
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.丙型肝炎抗病毒治疗作为惰性B细胞淋巴瘤的治愈性疗法。
World J Gastroenterol. 2016 Oct 14;22(38):8447-8458. doi: 10.3748/wjg.v22.i38.8447.
3
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.抗病毒治疗与利妥昔单抗联合治疗混合性冷球蛋白血症患者：文献综述及1例采用基于直接抗病毒药物的抗丙型肝炎病毒治疗的病例报告
Case Reports Immunol. 2015;2015:816424. doi: 10.1155/2015/816424. Epub 2015 Mar 1.
4
Non-Hodgkin lymphoma and hepatitis C: where we are and what next?非霍奇金淋巴瘤与丙型肝炎：现状与未来走向？
Pathol Oncol Res. 2015 Jan;21(1):1-7. doi: 10.1007/s12253-014-9845-z. Epub 2014 Oct 2.
5
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.与丙型肝炎病毒感染相关的惰性B细胞淋巴瘤：临床和病毒学特征以及抗病毒治疗的作用
Clin Dev Immunol. 2012;2012:638185. doi: 10.1155/2012/638185. Epub 2012 Aug 26.
本文引用的文献
1
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.利妥昔单抗联合聚乙二醇干扰素-α/利巴韦林与聚乙二醇干扰素-α/利巴韦林在丙型肝炎相关混合性冷球蛋白血症中的比较。
Blood. 2010 Jul 22;116(3):326-34; quiz 504-5. doi: 10.1182/blood-2009-10-248518. Epub 2010 May 3.
2
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.利妥昔单抗治疗丙型肝炎病毒相关混合性冷球蛋白血症伴严重肝脏疾病患者的安全性和疗效。
Blood. 2010 Jul 22;116(3):335-42. doi: 10.1182/blood-2009-11-253948. Epub 2010 Mar 22.
3
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.聚乙二醇干扰素-α、利巴韦林和利妥昔单抗联合治疗丙型肝炎病毒相关混合性冷球蛋白血症：一项长期研究。
Blood. 2010 Jul 22;116(3):343-53. doi: 10.1182/blood-2009-10-245878. Epub 2010 Mar 22.
4
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.利妥昔单抗联合或不联合聚乙二醇化干扰素α-2b加利巴韦林治疗严重丙型肝炎病毒相关性血管炎的疗效和耐受性：32例患者的长期随访研究
Arthritis Rheum. 2009 Aug;60(8):2531-40. doi: 10.1002/art.24703.
5
Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.丙型肝炎相关混合性冷球蛋白血症性血管炎的治疗。
Curr Opin Rheumatol. 2008 Jan;20(1):23-8. doi: 10.1097/BOR.0b013e3282f1330c.
6
Hepatitis C virus-related lymphoproliferative disorders: an overview.丙型肝炎病毒相关淋巴增殖性疾病：概述
World J Gastroenterol. 2007 May 7;13(17):2467-78. doi: 10.3748/wjg.v13.i17.2467.
7
Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.丙型肝炎病毒相关混合性冷球蛋白血症性血管炎的抗病毒治疗：一项长期随访研究。
Arthritis Rheum. 2006 Nov;54(11):3696-706. doi: 10.1002/art.22168.
8
Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.利妥昔单抗可诱导难治性丙型肝炎病毒相关冷球蛋白血症性血管炎缓解。
Ann Rheum Dis. 2003 Dec;62(12):1230-3. doi: 10.1136/ard.2002.004929.
9
Efficacy and safety of rituximab in type II mixed cryoglobulinemia.利妥昔单抗治疗II型混合性冷球蛋白血症的疗效与安全性。
Blood. 2003 May 15;101(10):3827-34. doi: 10.1182/blood-2002-09-2856. Epub 2003 Jan 30.
10
Rituximab for the treatment of type II mixed cryoglobulinemia.利妥昔单抗治疗II型混合性冷球蛋白血症
Haematologica. 1999 Dec;84(12):1157-8.
Zotero 插件